Jan 14 (Reuters) - The U.S. Food and Drug Administration approved Pfizer Inc's drug Cibinqo to treat eczema, a skin disease, the company said on Friday. (Reporting by Leroy Leo in Bengaluru; Editing by Arun Koyyur)